6640--Cepheid PCR Reagents

The Department of Veterans Affairs intends to procure Cepheid PCR reagents for the Dayton VA Medical Center to support a suite of molecular diagnostic tests. The VA has identified Cepheid as the only responsible source under FAR 6.302‑1(a)(2) but is allowing any other capable supplier to submit a capability notice by the deadline, which could potentially open the requirement to competition. No formal solicitation has been posted yet; the VA is gathering information to confirm sole‑source status. • Required product: Cepheid PCR reagents for tests such as FLUVID, COVID‑19, CARBA‑R, C. diff, CT/NG, MRSA, Strep A, TV, and MTB/RIF. • End‑user: Dayton Veterans Affairs Medical Center, Dayton, Ohio. • Sole‑source candidate: Cepheid (904 Caribbean Drive, Sunnydale, CA 94089). • Deadline for capability notice: October 8, 2026, 7:30 a.m. ET, emailed to the contract specialist with a specific subject line. • No quantity, pricing, or contract length is disclosed; the VA may award a supply contract if no other capable source is identified.